BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27148868)

  • 1. G1-4A, a Polysaccharide from Tinospora cordifolia Inhibits the Survival of Mycobacterium tuberculosis by Modulating Host Immune Responses in TLR4 Dependent Manner.
    Gupta PK; Chakraborty P; Kumar S; Singh PK; Rajan MG; Sainis KB; Kulkarni S
    PLoS One; 2016; 11(5):e0154725. PubMed ID: 27148868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.
    Yang F; Labani-Motlagh A; Bohorquez JA; Moreira JD; Ansari D; Patel S; Spagnolo F; Florence J; Vankayalapati A; Sakai T; Sato O; Ikebe M; Vankayalapati R; Dennehy JJ; Samten B; Yi G
    Commun Biol; 2024 Mar; 7(1):294. PubMed ID: 38461214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homodimeric Granzyme A Opsonizes Mycobacterium tuberculosis and Inhibits Its Intracellular Growth in Human Monocytes via Toll-Like Receptor 4 and CD14.
    Rasi V; Phelps KR; Paulson KR; Eickhoff CS; Chinnaraj M; Pozzi N; Di Gioia M; Zanoni I; Shakya S; Carlson HL; Ford DA; Kolar GR; Hoft DF
    J Infect Dis; 2024 Mar; 229(3):876-887. PubMed ID: 37671668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.
    Yi G; Yang F; Labani-Motlagh A; Moreira JD; Ansari D; Bohorquez JA; Patel S; Spagnolo F; Florence J; Vankayalapati A; Vankayalapati R; Dennehy JJDJ; Samten B
    bioRxiv; 2023 Feb; ():. PubMed ID: 36747734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LppM impact on the colonization of macrophages by Mycobacterium tuberculosis.
    Deboosère N; Iantomasi R; Queval CJ; Song OR; Deloison G; Jouny S; Debrie AS; Chamaillard M; Nigou J; Cohen-Gonsaud M; Locht C; Brodin P; Veyron-Churlet R
    Cell Microbiol; 2017 Jan; 19(1):. PubMed ID: 27220037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection.
    Banerjee SK; Kumar M; Alokam R; Sharma AK; Chatterjee A; Kumar R; Sahu SK; Jana K; Singh R; Yogeeswari P; Sriram D; Basu J; Kundu M
    Sci Rep; 2016 May; 6():25851. PubMed ID: 27181265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preprotein translocase YidC controls respiratory metabolism in Mycobacterium tuberculosis.
    Thakur P; Gantasala NP; Choudhary E; Singh N; Abdin MZ; Agarwal N
    Sci Rep; 2016 May; 6():24998. PubMed ID: 27166092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host immune responses to antigens derived from a predominant strain of Mycobacterium tuberculosis.
    Hur YG; Chung WY; Kim A; Kim YS; Kim HS; Jang SH; Kim Y; Lee H; Park KJ; Cho SN
    J Infect; 2016 Jul; 73(1):54-62. PubMed ID: 27155519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Secreted Antigenic Target of 6 kDa of Mycobacterium tuberculosis Stimulates Macrophage Chemoattractant Protein-1 Production by Macrophages and Its Regulation by p38 Mitogen-Activated Protein Kinases and Interleukin-4.
    Ma J; Jung BG; Yi N; Samten B
    Scand J Immunol; 2016 Jul; 84(1):39-48. PubMed ID: 27154637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis.
    Price DN; Kusewitt DF; Lino CA; McBride AA; Muttil P
    PLoS Pathog; 2016 May; 12(5):e1005614. PubMed ID: 27153120
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Gupta A; Gupta P; Bajpai G
    Heliyon; 2024 Feb; 10(4):e26125. PubMed ID: 38390130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling Various Facades of
    Anjum V; Bagale U; Kadi A; Potoroko I; Sonawane SH; Anjum A
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894552
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yang J; Zhang L; Qiao W; Luo Y
    MedComm (2020); 2023 Oct; 4(5):e353. PubMed ID: 37674971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of
    Gupta PK; Jahagirdar P; Tripathi D; Devarajan PV; Kulkarni S
    Front Immunol; 2023; 14():1233630. PubMed ID: 37583694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal Plants as Therapeutic Alternatives to Combat
    Gautam S; Qureshi KA; Jameel Pasha SB; Dhanasekaran S; Aspatwar A; Parkkila S; Alanazi S; Atiya A; Khan MMU; Venugopal D
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-Directed Therapies for Tuberculosis.
    Jeong EK; Lee HJ; Jung YJ
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations.
    Prajapati SK; Malaiya A; Mishra G; Jain D; Kesharwani P; Mody N; Ahmadi A; Paliwal R; Jain A
    J Ethnopharmacol; 2022 Oct; 296():115420. PubMed ID: 35654349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals.
    Fatima S; Kumari A; Dwivedi VP
    MedComm (2020); 2021 Dec; 2(4):494-513. PubMed ID: 34977867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-directed therapy to combat mycobacterial infections.
    Kilinç G; Saris A; Ottenhoff THM; Haks MC
    Immunol Rev; 2021 May; 301(1):62-83. PubMed ID: 33565103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune and adjuvant responses of mucosally-administered Tinospora cordifolia immunomodulatory protein in BALB/c mice.
    Aranha I; Venkatesh YP
    J Ayurveda Integr Med; 2020; 11(2):140-146. PubMed ID: 30455069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.